Article Text

Download PDFPDF

P15 Regional cerebral atrophy and cognitive function in Chronic Obstructive Pulmonary Disease
Free
  1. CC Savage1,
  2. C Pennington1,
  3. PW Jones2,
  4. JW Dodd1
  1. 1University of Bristol, Bristol, UK
  2. 2St George’s University of London, London, UK

Abstract

Background Widespread white matter damage and cognitive impairment have been demonstrated in COPD. However, it remains unclear if regional atrophy is present. We used a simple clinical visual rating scale to measure regional atrophy in a well-characterised population with COPD and compared age-matched controls. We explored correlations with demographics, disease factors and cognitive measures.

Objectives

  1. a) To determine if there are significant differences in regional atrophy between COPD patients and age-matched control subjects.

  2. b) To investigate whether patient characteristics or measures of disease severity account for group differences in atrophy severity.

  3. c) To seek correlations with regional atrophy.

Methods A validated visual analogue MRI grading technique was used to assess the degree of atrophy in multiple brain regions in stable non-hypoxaemic COPD patients (n = 25) and age-matched control subjects (n = 25). This study is a further analysis of a previous case-control multi modal cranial MRI study.1

Main results COPD patients had significantly greater frontal atrophy than control subjects (p = 0.01), this was independent of smoking history, comorbidities and hospital anxiety and depression scores. Cognitive function was significantly worse in the COPD group for executive function, working memory, verbal memory and processing speed. Group differences in atrophy did not seem to account for differences in cognitive function. We were unable to identify meaningful correlations between regional atrophy and disease severity or cognitive function.

Abstract P15 Table 1

Bilaterally summed composite scores for regional atrophy in the control and COPD group (presented as Mean ± SD)

Conclusions There is significant frontal brain atrophy in stable non-hypoxaemic COPD patients. This regional atrophy does not appear to be related to disease severity or cognitive function. Further work is needed to identify causative mechanisms behind this structural change.

Reference 1 Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med. 2012;186:240–245

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.